S&P 500 Healthcare Sector SEC Filings — May 14, 2026

14-05-2026

14-05-2026

14-05-2026

Signet Jewelers' 2026 Proxy Statement details a Board committee restructuring in August 2025, separating the former Governance & Technology Committee into Governance, Nominations & Sustainability (GNS) and Technology (TC) committees, while eliminating the standalone Corporate Citizenship & Sustainability Committee and reallocating its duties. Committee compositions as of May 14, 2026 are provided, with all members independent under NYSE standards, and Fiscal 2026 meeting counts include Audit (6), Finance (6), GNS (1), HCMC (7), and TC (1). References to Pay vs. Performance disclosures for PEO Virginia C. Drosos and J.K. Symancyk across fiscal years ending 2022 through 2026 are included via XBRL tags, with no specific compensation values detailed.

• · All Board Committee members are independent under NYSE Listing Standards; Audit and Finance members are financially literate, with Audit members as audit committee financial experts.
• · Fiscal years referenced: 2022 (ended 2022-01-29), 2023 (ended 2024-02-03), 2024 (ended 2025-02-01), 2025 (ended 2026-01-31), and prior periods.
• · Audit Committee now oversees external sustainability-related reporting; HCMC has sole responsibility for human capital matters including culture, diversity, and inclusion.

14-05-2026

14-05-2026

Cellectar Biosciences reported positive 12-month follow-on data from the CLOVER-WaM Phase 2b study of iopofosine I 131 in r/r WM, achieving 61.8% major response rate, 83.6% overall response rate, median DoR of 17.8 months, and median PFS of 13.5 months, supporting plans for a Phase 3 confirmatory trial and FDA accelerated approval filing. The company completed a financing of up to $140 million ($35 million upfront plus $105 million milestone-based) led by Nantahala Capital, dosing first patients in CLR 125 Phase 1b for TNBC. Q1 2026 net loss improved to $5.7 million ($1.33/share) from $6.6 million ($4.30/share) YoY, with R&D and G&A expenses decreasing, though cash fell to $8.3 million from $13.2 million QoQ.

• · Phase 3 confirmatory study: randomized controlled with ~100 WM patients per arm, full enrollment in 18-24 months.
• · ASCO 2026 poster presentation on June 1, 2026, 9:00 AM – 12:00pm CDT (Poster 592).
• · Cash runway: adequate into Q2 2027 with May 2026 financing.
• · Median duration of response (DoR): 17.8 months; Median PFS: 13.5 months in CLOVER-WaM.

14-05-2026

Western New England Bancorp, Inc. (WNEB) presented at its 2026 Annual Shareholders’ Meeting, highlighting 2025 quarterly financials with net income improving to $5,209 thousand in 4Q2025 (EPS $0.26, ROA 0.75%) from $2,303 thousand in 1Q2025 (EPS $0.11, ROA 0.35%), and Q1 2026 results showing EPS of $0.24 (up YoY from $0.11 but down QoQ from $0.26) with ROA at 0.71% (up YoY but down QoQ from 0.75%). Balance sheet grew with total loans at $2.3 billion as of March 31, 2026 (up from $2.1 billion YoY) and deposits at approximately $2.4 billion, while NIM improved to 2.97% tax-equivalent basis in Q1 2026 (up QoQ from 2.91%). However, ROE declined QoQ to 7.77% from 8.40%, and certain quarters showed provisions for credit losses.

• · Shareholder proposals include election of four directors (Laura J. Benoit, Donna J. Damon, Lisa G. McMahon, Steven G. Richter) for three-year terms, advisory vote on executive compensation, and ratification of Wolf & Company, P.C. as independent auditor for FY 2026.
• · Strong asset quality in 2025: Allowance for Credit Losses at 0.93% of total loans, coverage of nonaccrual loans at 393%, nonaccrual loans 0.32% of total loans.
• · Loan-to-asset ratio reached 80% in 2025, up from 73% historically; borrowings-to-total assets at 4%.

14-05-2026

Lifeway Foods reported record Q1 2026 net sales of $63.0 million, up 36.7% YoY from $46.1 million, driven by 37% volume-led growth in Lifeway Kefir and Farmer Cheese, with gross profit margin expanding 360 basis points to 27.5%. Net income rose 32% to $4.7 million ($0.30 diluted EPS), reflecting operational execution, though SG&A expenses increased 16.8% to $10.9 million amid marketing investments. The company drew $6.9 million on its line of credit to fund $11.0 million in capex, supporting growth outlook including $45-50 million Adjusted EBITDA target for FY2027.

• · Total assets increased to $120.5 million as of March 31, 2026 from $105.6 million at December 31, 2025.
• · Property, plant and equipment, net rose to $57.8 million from $48.3 million QoQ due to capex.
• · Net cash provided by operating activities was $4.4 million in Q1 2026 vs used $0.2 million in Q1 2025.
• · 26th consecutive quarter of year-over-year net sales growth.
• · Recognized as Dairy Foods' Processor of the Year 2025 and other awards.

14-05-2026

News Corporation filed an 8-K disclosing information provided to the Australian Securities Exchange (ASX) regarding its ongoing stock repurchase program, under which the company is authorized to acquire up to $1 billion in aggregate of its Class A common stock (NWSA) and Class B common stock (NWS). The disclosures, dated as noted in Exhibits 99.1 and 99.2, include daily transaction updates if any under the program, as required by ASX rules. No specific repurchase transactions are detailed in the filing body.

• · Filing date: May 14, 2026
• · Date of earliest event reported: May 13, 2026
• · Securities: Class A Common Stock (NWSA, par value $0.01), Class B Common Stock (NWS, par value $0.01), traded on Nasdaq Global Select Market

14-05-2026

New Fortress Energy Inc. reported total revenues of $226,953 thousand for the three months ended March 31, 2026, down 52% YoY from $472,282 thousand, leading to a sharply wider operating loss of $(225,375) thousand and net loss of $(400,604) thousand (EPS $(1.40)) compared to $(175,426) thousand (EPS $(0.65)) in Q1 2025, driven by declines across revenue streams and spikes in transaction costs (+346%) and asset impairments. Operating cash use worsened to $(118,902) thousand from $(7,237) thousand, with cash and equivalents plus restricted cash falling to $189,881 thousand. However, the company holds a $10,304,872 thousand revenue backlog extending through 2030 and beyond.

• · Asset impairment expense surged to $61,864 thousand in Q1 2026 from $246 thousand YoY.
• · Cash, cash equivalents and restricted cash decreased by $167,061 thousand during Q1 2026.
• · Contract assets, net decreased to $20,113 thousand as of March 31, 2026 from $32,166 thousand at Dec 31, 2025.

14-05-2026

New America Acquisition I Corp., a SPAC, reported net income of $2,059,655 for the three months ended March 31, 2026, driven by $3,002,063 in interest income from the trust account offsetting a $311,975 operating loss. Cash held in the trust account grew 0.87% to $348,919,571, contributing to total assets rising 0.84% to $350,360,414; however, operating cash declined 9.37% to $855,526, total liabilities more than doubled to $1,724,935, and shareholders' equity fell 35.02% to $578,883. Per share net income was $0.04 for both redeemable and non-redeemable shares.

• · Provision for income taxes: $630,433 for the three months ended March 31, 2026.
• · Net cash used in operating activities: $88,580 for the three months ended March 31, 2026.
• · Non-cash remeasurement of Class A common stock subject to possible redemption: $2,371,630.
• · Income tax payable increased to $862,975 as of March 31, 2026.
• · Accounts payable increased to $111,019 as of March 31, 2026.

14-05-2026

Editas Medicine reported new preclinical data at the 2026 ASGCT Annual Meeting demonstrating that a single dose of EDIT-401 achieved 90% or greater mean LDL-C reduction in non-human primates, with durable effects through six months, moderate 10-40% functional editing of LDLR alleles, and a six-fold or greater mean increase in hepatic LDLR protein. The data showed a promising safety profile with no adverse observations at the 1.5 mg/kg dose and highest delivery in hepatocytes with undetectable oocyte delivery. Additional mouse data supports no dose adjustments needed for HeFH patients.

• · Dose levels evaluated: 1.5 mg/kg - 3.0 mg/kg
• · LDL-C lowering rapid and durable through approximately six months
• · No adverse clinical observations at therapeutically relevant dose (1.5 mg/kg)
• · Highest delivery of EDIT-401 in hepatocytes vs. other non-target tissues
• · Undetectable oocyte delivery
• · Mouse data: PK/PD of single dose EDIT-401(mu) in heterozygous Ldlr loss-of-function and wildtype mice

14-05-2026

For the three months ended March 31, 2026, revenues surged 321% YoY to $188,756 driven by retail trading revenue of $182,278 (up 307% YoY), with gross profit rising 200% YoY to $59,068. However, selling, general and administrative expenses ballooned to $161,140 (over 1,169% increase YoY), leading to an operating loss of $102,072 versus a $6,994 profit in Q1 2025, and net cash used in operations widened to $71,811. Cash and equivalents fell sharply 78% QoQ to $15,332 from $68,888, while total stockholders' equity plummeted 90% QoQ to $11,427 from $113,391.

• · Amount due to related party increased to $110,610 as of March 31, 2026 from $78,260 as of Dec 31, 2025.
• · Amount due to a director rose to $21,188 as of March 31, 2026 from $15,565 as of Dec 31, 2025.
• · Net cash used in operating activities was $71,811 in Q1 2026 vs $4,832 in Q1 2025.
• · Right-of-use assets include $27,840 from related party as of March 31, 2026.

14-05-2026

Sumitomo Mitsui Financial Group, Inc. filed its 13F-HR on May 14, 2026, disclosing institutional holdings as of March 31, 2026, across subsidiaries including Sumitomo Mitsui Banking Corporation and SMBC Nikko Securities Inc. The portfolio features large positions such as Ares Management Corporation ($1.458B), Jefferies Financial Group Inc. ($382M), SPDR Gold Trust ($254M), and Polestar Automotive ($190M), alongside ETFs and tech stocks like NVIDIA ($82M). No prior period data is provided for comparisons, with holdings including both common shares and options.

• · Filing period end date: March 31, 2026
• · Includes positions in call and put options on stocks like Uber Technologies, Qualcomm, and Verizon
• · Portfolio managed under multiple CIK numbers including 028-17794, 028-17800, 028-18879

14-05-2026

Hewlett Packard Enterprise Company closed the sale of 13.8% of the total issued share capital of H3C Technologies Co., Limited to various Chinese counterparties for approximately USD $986.8 million on May 13, 2026. The company expects to close the sale of its remaining 5.2% stake in H3C to Unisplendour International Technology Limited for approximately USD $370.4 million in the first half of calendar 2026. No declines or flat performance metrics were reported in this transaction update.

• · Share Purchase Agreements entered into on November 17, 2025 and November 28, 2025, as previously disclosed in 8-K filings on November 17, 2025 and December 1, 2025
• · Transaction closed on May 13, 2026 (filing date May 14, 2026)

14-05-2026

Panview Capital Ltd filed its 13F-HR on May 14, 2026, reporting $467,216,851 in total holdings value as of March 31, 2026, across 12 equity positions, all held with sole voting power. Top positions include AppLovin Corp ($87,434,232 market value, 219,684 shares), CoreWeave Inc ($69,472,152, 896,762 shares), Nokia Corp ($47,925,893, 5,960,932 shares), NVIDIA Corp ($48,832,000, 280,000 shares), and VanEck Gold Miners ETF ($43,879,458, 478,146 shares). No prior period comparison data is available in the filing.

• · Filing period end date: March 31, 2026
• · All positions held with sole voting power and no shared power
• · Firm located at Unit 2, 28/F, The Centrium, 60 Wyndham Street, Central, Hong Kong

14-05-2026

Novak & Powell Financial Services, Inc. filed its 13F-HR report on May 14, 2026, disclosing 164 equity holdings totaling $185626233 as of March 31, 2026, all held with sole voting authority. The portfolio is diversified across individual stocks and ETFs, with top positions including Vanguard Growth ETF (25831 shares valued at $11282635), Apple Inc. (38991 shares valued at $9895505), and Vanguard Large-Cap ETF (28637 shares valued at $8558279). No other voting authority or discretion is reported.

• · Report period end: March 31, 2026
• · All 164 positions held as sole voting authority (SH SOLE)
• · No shared or other voting authority reported

14-05-2026

Senti Biosciences reported Q1 2026 financial results with net loss reduced to $4.2 million from $14.1 million YoY, driven by lower R&D expenses ($5.3 million vs $9.3 million) and G&A ($6.2 million vs $7.1 million), plus a $6.9 million gain on lease modification; cash burn decreased to $7.5 million from $14.1 million. However, cash and equivalents fell to $8.9 million from $16.4 million at year-end 2025. Business highlights include positive FDA feedback supporting a single-arm pivotal trial for SENTI-202 in R/R AML and a strategic financing agreement for up to $40 million.

• · SENTI-202 achieved durable MRD-negative responses in full 22-patient Phase 1 trial.
• · Donor X attribute used in all future SENTI-202 manufacturing, found in ~50% of adult donors.
• · Strategic financing includes initial $10M tranche and up to $30M additional, plus $60M contingent value rights.
• · FDA granted RMAT and Orphan Drug Designation to SENTI-202 for R/R hematologic malignancies including AML.
• · Revenue - related party: $16 thousand in Q1 2026 vs $0 in Q1 2025.

14-05-2026

Tradewinds Universal reported Q1 2026 revenue of $21,800, up 68% YoY from $12,972, with gross profit also rising to $21,800. However, operating expenses exploded to $147,141 from $14,084 YoY, driven by marketing ($64,178), consulting ($43,700), and professional fees ($23,796), leading to a net loss of $125,341 versus $1,112 last year. Total assets fell 7.6% QoQ to $283,992 from $307,333, cash dipped to $15,597, and new liabilities of $52,000 emerged.

• · Marketing expenses: $64,178 in Q1 2026 (none in Q1 2025)
• · Consulting expenses: $43,700 in Q1 2026 vs $12,650 in Q1 2025
• · Amortization expense: $10,000 in Q1 2026 vs $1,200 in Q1 2025
• · Net cash used in operating activities: $(76,041) in Q1 2026 vs $88 provided in Q1 2025
• · Financing activities: $75,000 from loan ($25,000) and common stock ($50,000) in Q1 2026
• · 1,946,667 warrants outstanding with weighted average exercise price $0.06, expiring 2028-2029

14-05-2026

Seaview Investment Managers LLC filed its 13F-HR on May 14, 2026, disclosing institutional equity holdings as of March 31, 2026, across approximately 205 positions primarily categorized as DFND, SOLE, and OTR managed accounts. Top holdings by market value include McKesson Corp (7397097 DFND), Netflix Inc (7332287 DFND), Itau Unibanco Hldg (7176976 DFND), Barrick Mng Corp (6710813 DFND), and Oracle Corp (6239180 DFND), with significant exposure to tech stocks, ETFs, precious metals, and international equities. No prior period data is provided in the filing for comparison.

• · Holdings managed across SOLE (sole discretion), DFND (defined), and OTR (other) categories.
• · Firm address: 2 Alhambra Plaza Suite 802, Miami, FL 33134.
• · Former name: Claudia M.P. Batlle, CRP (R) LLC (changed November 12, 2020).

14-05-2026

Federal Home Loan Bank of Cincinnati filed an 8-K under Item 2.03 reporting a new Consolidated Bond issuance for which it is the primary obligor, with a par value of $10,000,000 at a fixed rate of 4.400%. The bond (CUSIP 3130BAQS9) was traded on May 12, 2026, settles on May 18, 2026, matures on May 18, 2029, and has a next pay date of November 18, 2026, with Optional Principal Redemption (Bermudan style). No period-over-period comparisons or other financial metrics were provided.

• · Call Type: Optional Principal Redemption
• · Call Style: Bermudan
• · Next Call/Amort Date: November 18, 2026
• · Consolidated Obligations are joint and several obligations of the 11 Federal Home Loan Banks, backed only by their financial resources, not guaranteed by the U.S. government

14-05-2026

Sun Life Financial Inc, along with affiliates Massachusetts Financial Services Co /MA/, Sun Life Capital Management (U.S.) LLC, Sun Life Assurance Co of Canada, and Crescent Capital Group LP, filed a 13F-HR report disclosing U.S. equity holdings as of March 31, 2026. The portfolio emphasizes S&P 500-related ETFs with top positions including SPDR S&P 500 ETF Trust at $364.477M, Xtrackers S&P 500 Scored & Screened ETF at $280.418M, and Vanguard S&P 500 ETF at $279.693M. Additional holdings span international ETFs like iShares MSCI Taiwan ETF ($117.198M) and various REITs such as Digital Realty Trust and Prologis Inc., all with sole voting power.

• · All disclosed positions held with sole voting power (SH SOLE).
• · Filing date: May 14, 2026.
• · Report period end: March 31, 2026.
• · Additional S&P 500 ETF positions: SPDR S&P 500 ETF Trust $4.748M and iShares Core S&P 500 ETF $0.699M (aggregated smaller).
• · REIT holdings include Prologis Inc (7,682 shares, $10.15M value? wait, value before shares: 1015 value $1.015M).

14-05-2026

Fieldview Capital Management, LLC filed its 13F-HR on May 14, 2026, disclosing 468 equity holdings totaling $342,580,172 as of March 31, 2026, all held with sole discretionary voting power. The portfolio spans diverse sectors including financials (e.g., AGNC Investment Corp at $1,882,491), real estate (e.g., Broadstone Net Lease Inc at $2,802,728), and technology (e.g., DLocal Ltd at $1,518,644). No prior period data is provided in the filing for comparison.

• · All 468 positions reported as SH SOLE with sole shares and no shared/other voting power.
• · Portfolio address: 2003 Morris Drive, Niles, MI 49120.
• · SEC file number: 028-25207; CIK: 0002040221.

14-05-2026

Migdal Insurance & Financial Holdings Ltd. filed its Form 13F-HR on May 14, 2026, disclosing U.S. equity holdings as of March 31, 2026, managed by its wholly-owned subsidiaries including Migdal Insurance Company Ltd., Migdal Makefet Pension and Provident Fund Ltd., Migdal Mutual Funds Ltd., and Migdal Investment Portfolio Management (1998) Ltd. Key positions include Alphabet Inc. CAP STK CL C valued at $440,308,016 (1,535,050 shares), Invesco Exchange Traded Fund Trust II S&P500 EQL WGT at $364,648,000 (1,900,000 shares), and Amazon.com Inc. COM at $297,436,635 (1,428,130 shares). The filing notes independent management by each entity and includes only U.S.-purchased dual-listed securities per SEC guidance.

• · Beneficial ownership in a portion of securities held for members of the public through provident funds, mutual funds, pension funds, and insurance policies.
• · Each Migdal Entity operates under independent management with independent voting and investment decisions.
• · Filing disclaims formation of any 'group' under Section 13(d) and beneficial ownership beyond actual pecuniary interest.
• · Dual-listed securities (U.S. and Tel Aviv Stock Exchange) included only if purchased in the U.S., per informal SEC guidance.

14-05-2026

On May 12, 2026, First Real Estate Investment Trust of New Jersey, Inc. (FREVS) and Computershare Trust Company, N.A. entered into the First Amendment to the Stockholder Rights Agreement originally dated July 31, 2023. The amendment extends the Final Expiration Date of the agreement from July 31, 2026, to July 31, 2029. No financial terms or performance metrics were disclosed.

• · Filing date: May 14, 2026; Earliest event date: May 12, 2026.
• · Registrant details: Maryland incorporation, Commission File Number 000-25043, IRS Employer Identification No. 22-1697095.
• · Securities: Common stock (FREVS) on OTC Pink Market; Preferred Stock Purchase Rights registered via Form 8-A on August 3, 2023.
• · Exhibit 4.1: First Amendment to Stockholder Rights Agreement.

14-05-2026

Aldebaran Financial Inc. filed its 13F-HR on May 14, 2026, disclosing $105288494 in total market value of equity holdings as of March 31, 2026, across 76 positions all held with sole discretionary authority. Top holdings include SPDR Series Trust State Street SPD (78464A805) at $8250132 (104353 shares), Berkshire Hathaway Inc Del Cl B New at $7481750 (15613 shares), and Apple Inc at $6220767 (24511 shares). No prior period comparisons or changes are provided in this routine quarterly disclosure.

• · All holdings reported with sole voting and investment authority (SH SOLE); no other managers, put/call options, or shared authority.
• · Report signed by Peter W. Raber on 04-27-2026.
• · SEC file number: 028-15879; Central Index Key: 0001353110.

14-05-2026

Weaver C. Barksdale & Associates, Inc., an investment manager based in Nashville, TN, filed its quarterly 13F-HR report on May 14, 2026, disclosing holdings of 62 equity securities totaling $104,872,915 as of March 31, 2026. All positions are held with sole voting and investment discretion, with no shared or other discretion reported. Notable holdings include AbbVie Inc. ($2,154,676), AES Corp. ($2,204,596), and Accenture PLC ($1,900,202).

• · All holdings reported as 'SH SOLE' with zero shared or none voting power.
• · No changes or prior period data disclosed in this filing.
• · Filer CIK: 0001294588, SEC File Number: 028-10931.

14-05-2026

For the three months ended March 31, 2026, UMeWorld Inc. reported revenue of $351,187, a massive increase from $411 YoY, with gross income turning positive at $15,152 versus a $1,724 loss. However, operating expenses surged to $120,631 from $19,266, widening the net loss to $105,450 from $20,958, while for the six months, revenue reached $498,642 from $606 but net loss expanded to $244,177 from $35,668. Total assets grew to $1,521,485 from $170,409 at September 30, 2025, driven by inventory to $1,367,582, though liabilities of $1,735,745 exceed assets resulting in a stockholders' deficit of $214,260.

• · Net cash used in operating activities for six months ended March 31, 2026: $362,736 (vs $111,371 in 2025).
• · Proceeds from issuance of common stock and loan conversion: $353,646 in three months ended March 31, 2026.
• · Four wholly-owned subsidiaries: Dagola Inc. (US, cooking oil), Dagola HK (inactive holding), Guangzhou Duokanglong (China, cooking oil), Verdant Malaysia (SAF project development).

14-05-2026

Greenland Mines Ltd (NASDAQ: GRML) furnished an investor presentation by President Bo Møller Stensgaard, Ph.D., on May 14, 2026, detailing the Skaergaard PGM-Au-V-Ga-Fe-Ti Project in Southeast Greenland, which hosts a Mineral Resource of 159 Mt Indicated and 205 Mt Inferred with a gross in-situ contained metal value of approximately $68 Billion at February 2026 prices. The company plans additional drilling and technical studies to expand and upgrade the resource and evaluate by-product opportunities in vanadium, gallium, iron, and titanium. A related press release was issued on May 13, 2026.

• · Presentation hosted by Critical Minerals Institute at The National Club, Toronto, on May 14, 2026.
• · NI 43-101 Technical Report on Skaergaard Project dated November 30, 2022.
• · Securities: Common Stock (GRML) and Warrants (GRMLW) on Nasdaq Stock Market LLC.
• · Former name change to Greenland Mines Ltd on October 1, 2024.

14-05-2026

HRT Financial LP filed its 13F-HR on May 14, 2026, reporting equity holdings as of March 31, 2026. The portfolio comprises 3738 positions across diverse sectors including technology, healthcare, and consumer goods, with a total market value of $40051985000. Notable holdings include Apple Inc (value $301359000), AbbVie Inc (value $201484000), and Alphabet Inc Class C (value $114953000).

• · Filing date: May 14, 2026
• · Report period end date: March 31, 2026
• · Filer CIK: 0001475597
• · Business address: 3 World Trade Center, 175 Greenwich St, 76th Floor, New York, NY 10007
• · All positions reported as sole discretionary (DFND) with no put/call options

14-05-2026

CIBC World Market Inc. filed its 13F-HR on May 14, 2026, disclosing 1463 equity positions held as of March 31, 2026, with a portfolio heavily weighted toward Canadian financial institutions and resource companies. Top holdings by market value include Bank Nova Scotia ($1801039557), Bank Montreal ($1785620765), Apple Inc. ($889282538), Brookfield Corp ($796317911), and Amazon.com Inc. ($726673340). No prior period comparisons are provided in the filing.

• · Filing covers period ending March 31, 2026
• · Includes holdings in puts and calls for select positions such as Bank Nova Scotia (673800 SH Put, 630000 SH Call) and BCE Inc. (2000000 SH Put, 481500 SH Call)

14-05-2026

RM Financial Services, LLC filed Form 13F-HR on May 14, 2026, disclosing $115,953,937 in total holdings value as of March 31, 2026, across 75 positions, all held solely on a discretionary basis with no shared voting authority. Largest positions include Capital Group Dividend Grower ETF valued at $11,044,286 (307,640 shares) and World Gold TR SPDR GLD Minishares valued at $10,685,396 (115,281 shares). No prior period comparisons or performance metrics were provided in the filing.

• · All positions reported as SH SOLE with zero put/call options, zero other manager shares.
• · Report period end: 03/31/2026
• · No changes reported (DATE AS OF CHANGE: 20260514 matches filing date)

14-05-2026

Catalys Pacific, LLC filed its 13F-HR report disclosing holdings as of March 31, 2026, with total reported value of $230,711,689 across two positions. Key holdings include Mineralys Therapeutics, Inc. valued at $214,114,971 (7,903,838 shares sole) and Phathom Pharmaceuticals, Inc. valued at $16,596,718 (1,493,854 shares sole). No changes or prior period comparisons are detailed in the filing.

• · Filing period end date: March 31, 2026
• · Filed on May 14, 2026
• · Filer CIK: 0002011385
• · All holdings reported as sole voting authority with zero shared, zero call/put options

14-05-2026

Bright Financial Advisors, Inc. filed its 13F-HR on May 14, 2026, disclosing 67 equity positions totaling $218,243,003 as of March 31, 2026. The portfolio features heavy weighting in fixed income and gold ETFs, with the largest holding being iShares Core U.S. Aggregate Bond ETF at $35,848,284, followed by SPDR Gold Shares at $23,788,153 and Invesco S&P 500 Equal Weight ETF at $20,946,388. All positions are held with sole voting authority and no other managers reported.

• · Report period end date: 2026-03-31
• · Filed as of date: 2026-05-14
• · All holdings reported with sole voting authority (SH SOLE)

14-05-2026

Public Employees Retirement Association of Colorado filed its 13F-HR report on May 14, 2026, disclosing equity holdings as of March 31, 2026, across 1,848 securities with a total market value of $25,482,472,000. Notable positions include Apple Inc (value $1,719,218,000, 6,774,177 shares), Amazon.com Inc (value $1,007,766,000, 4,838,746 shares), Alphabet Inc Class A (value $1,311,198,000, 4,559,738 shares), and Alphabet Inc Class C (value $179,403,000, 625,401 shares). The filing provides a snapshot of sole discretionary holdings with no period-over-period changes detailed.

• · Report filed under SEC file number 028-00817
• · All positions reported as sole voting authority (SH SOLE)

14-05-2026

Financial Engines Advisors L.L.C. filed a 13F-HR on May 14, 2026, disclosing its U.S. equity holdings as of March 31, 2026, primarily consisting of ETFs from iShares and Dimensional with sole voting power across all positions. Notable top holdings include $1.71B in iShares Russell 1000 Value ETF and $1.19B in iShares iBoxx $ Investment Grade Corporate Bond ETF, alongside significant allocations to broad market equity and fixed income index funds. No period-over-period changes are provided in this snapshot filing.

• · Filing covers period ending March 31, 2026 (Q1 2026).
• · All positions reported with sole voting power (SH SOLE).
• · Business address: 3945 Freedom Circle, Suite 450, Santa Clara, CA 95054.
• · SEC file number: 028-12703.

14-05-2026

Monte Financial Group, LLC filed its Form 13F-HR on May 14, 2026, disclosing 100 equity holdings as of March 31, 2026, with a total market value of $281,598,010. Top positions include Johnson & Johnson ($8,270,881), Chevron Corporation ($8,027,202), and RTX Corporation ($7,518,936), alongside other large-cap names like Wells Fargo & Co ($6,904,277) and Baker Hughes Company ($6,902,091). All holdings are reported with sole ownership and voting power; no period-over-period changes are provided in this filing.

• · Firm address: 30 Long Hill Road, Guilford, CT 06437
• · All positions held with sole voting power (SH SOLE); no shared power, put/call options, or other manager discretion reported
• · Portfolio includes ETFs such as iShares Core S&P 500 ETF and Fidelity Covington Trust sector index funds

14-05-2026

Fiduciary Management Inc /WI/ filed its 13F-HR on May 14, 2026, for the quarter ended March 31, 2026, disclosing 63 equity holdings with a total market value of $8,146,802,839. Top positions include Aramark (10,587,895 shares valued at $429,233,263), Charles Schwab Corp (3,465,521 shares valued at $325,689,664), and Ferguson Enterprises (1,337,332 shares valued at $311,946,062). No prior period data or changes are provided in the filing.

• · Filing reports sole voting authority on all listed positions.
• · Headquartered at 790 N. Water Street, Suite 2100, Milwaukee, WI 53202.

14-05-2026

Chou Associates Management Inc. filed its 13F-HR report disclosing $210,266,544 in total holdings across 31 positions as of March 31, 2026, all held solely. Top positions by value include Berkshire Hathaway Inc. Del Cl A ($61,760,065 for 86 shares), Alphabet Inc. Cap Stk Cl C ($20,765,795 for 72,390 shares), and Occidental Pete Corp. ($20,345,004 for 313,000 shares). Other notable holdings feature Synchrony Financial ($15,182,205 for 223,202 shares) and Apple Inc. ($11,166,760 for 44,000 shares).

• · Ally Finl Inc: $8,847,349 for 225,525 shares
• · Paypal Hldgs Inc: $7,571,505 for 167,400 shares
• · SiriusXM Holdings Inc: $9,453,319 for 409,589 shares
• · Stellantis N.V: $9,884,838 for 1,394,194 shares
• · MBIA Inc: $1,897,110 for 321,000 shares

14-05-2026

Newport Trust Company, LLC filed a 13F-HR report disclosing 64 equity positions with a total market value of $40,727,980,409 as of March 31, 2026. Top holdings by value include Boeing Co ($5,705,159,921), AT&T Inc ($5,202,978,453), Parsons Corp ($2,716,013,123), GE Aerospace ($2,710,302,026), and Dillard's Inc Cl A ($2,581,461,583). The report was filed on May 14, 2026, and signed by William E. Ryan, III.

• · Filing submitted on May 14, 2026 for period ending March 31, 2026
• · Headquartered in Washington, DC

14-05-2026

PlanVest Financial, Inc. filed a 13F-HR report disclosing $131496053 in total portfolio value across 565 equity positions as of March 31, 2026, all held with sole voting power. Top holdings include Invesco QQQ Trust Series I ETF at $3359053 (5819 shares), State Street Technology Select Sector SPDR ETF at $2821572 (21230 shares), and SPDR S&P 500 ETF Trust at $3489424 (5365 shares). The filing provides a snapshot of diversified holdings in stocks and ETFs with no period-over-period comparisons available.

• · Filing submitted by Sean Flynn, Compliance Officer, on May 14, 2026.
• · Company address: 9711 Washingtonian Blvd, Suite 550, Gaithersburg, MD 20878.
• · All positions reported with sole discretionary and voting power (SH SOLE).

14-05-2026

Pacific Financial Group Inc reported total 13F holdings of $185,579,098 across 87 positions as of March 31, 2026, primarily consisting of diversified ETFs focused on U.S. equities, fixed income, international markets, and commodities. Top holdings include iShares Core S&P 500 ETF ($20,971,048), Invesco QQQ Trust Series 1 ($12,579,461), iShares S&P 500 Growth ETF ($10,271,072), and SPDR S&P 500 ETF Trust ($9,448,303). The filing provides a quarterly snapshot with no period-over-period changes disclosed.

• · All positions held with sole investment discretion (SH SOLE)
• · Business address: 900 20TH AVENUE SOUTH SUITE 500, NASHVILLE TN 37212
• · Filing CIK: 0001279926

14-05-2026

Baird Financial Group, Inc. (BFG), parent holding company of Robert W. Baird & Co. Incorporated, Strategas Asset Management, LLC, Baird Trust Company, Baird Financial Corporation, and Vident Advisory, LLC, filed a 13F-HR on May 14, 2026, reporting equity holdings as of March 31, 2026. The filing discloses positions across multiple managers in over 200 securities, including major stakes in Apple Inc. (total shares 5,102,348 for manager 1), Alphabet Inc. Class C (shares 2,267,930 for manager 1), and Amazon.com Inc. (shares 2,696,328 for manager 1). BFG disclaims investment discretion and beneficial ownership of all reported securities.

• · Filing period end date: March 31, 2026
• · Filer CIK: 0001648711
• · SEC file number: 028-16981
• · Business address: 777 E. Wisconsin Avenue, Milwaukee, WI 53202

14-05-2026

The Federal Home Loan Bank of San Francisco reported the creation of a direct financial obligation via a consolidated obligation bond with a bank par amount of $15,000,000, traded on May 12, 2026, settling May 18, 2026, and maturing May 18, 2029. The bond carries a fixed constant coupon rate of 4.351% with next pay date and optional Bermudan call on November 18, 2026. This issuance is part of routine funding through capital markets, jointly backed by the eleven Federal Home Loan Banks but not guaranteed by the U.S. government.

• · Trade date: May 12, 2026
• · Settlement date: May 18, 2026
• · Maturity date: May 18, 2029
• · Next pay date: November 18, 2026
• · Next call date: November 18, 2026
• · Call type: Optional Principal Redemption
• · Call style: Bermudan
• · CUSIP: 3130BAQE0

14-05-2026

Sixth Street Specialty Lending, Inc. entered into a Third Supplemental Indenture dated May 14, 2026, with U.S. Bank Trust Company, National Association, for the issuance and sale of $300,000,000 aggregate principal amount of 5.650% notes due August 15, 2031. The unsecured notes bear interest at 5.650% per year, payable semiannually commencing February 15, 2027, with proceeds intended to repay debt under the revolving credit facility and fund general corporate purposes including new investments. The transaction closed on May 14, 2026, pursuant to an effective Form N-2 registration statement.

• · Notes are direct unsecured obligations of the Company and may be redeemed in whole or in part at the Company's option.
• · Indenture covenants require compliance with Section 18(a)(1)(A) as modified by Section 61(a) of the Investment Company Act of 1940, subject to exemptions.
• · Upon a change of control repurchase event (change of control plus below investment grade rating), Company must offer to repurchase notes at 100% of principal plus accrued interest.

14-05-2026

Caxton Associates LLP filed its quarterly 13F-HR report disclosing 755 equity positions held solely, with a total market value of $4,417,494,302 as of March 31, 2026. Top holdings by market value include Advanced Micro Devices Inc ($253,005,891 for 1,243,700 shares), Amazon.com Inc ($202,272,032 for 971,201 shares), Apple Inc ($131,361,196 for 517,598 shares), Boeing Co ($121,706,845 for 611,500 shares), and Chart Industries Inc ($40,136,378 for 194,130 shares). No period-over-period changes or performance metrics are provided in this snapshot filing.

• · Filing date: May 14, 2026
• · Report period end date: March 31, 2026
• · All reported holdings held with sole investment discretion
• · Former name: Caxton Europe LLP (changed January 8, 2025)

14-05-2026

Massachusetts Financial Services Co /MA/ filed its 13F-HR on May 14, 2026, disclosing institutional equity holdings as of March 31, 2026, across 9 affiliated investment management entities including MFS Institutional Advisors, Inc. and others. The portfolio features substantial positions in healthcare names like Abbott Laboratories (e.g., values of 62249185, 107954425, 1197088463) and AbbVie Inc., technology giants such as Accenture PLC (e.g., 133959457), Alphabet Inc., and Amazon.com Inc. (e.g., 4021713694), with no prior period data provided for direct comparisons.

• · Positions include shared voting authority details (SOLE, DFND) across managers with some changes indicated (e.g., +43632 shares for Abbott Laboratories SOLE)
• · Filer CIK: 0000912938, SEC file number: 028-04968
• · Business address: 111 Huntington Avenue, 24th Floor, Boston, MA 02199